Search alternatives:
table 11a » table 11, table 1a, table 11.1
table 1 » table 2
table b » table 2, table 3, table 4

1
by Rao, Ghanta N.
Published 2001
United States Department of Health and Human Services, Public Health Service, National Institutes of Health

2
by Rao, Ghanta N.
Published 2001
United States Department of Health and Human Services, Public Health Service, National Institutes of Health

3
by Henrikson, Nora Beidler
Published 2019
Agency for Healthcare Research and Quality
...Twelve of 18 cases (66.7%) were detected at stage I or II or classified as "resectable." Pooled...

4
by Henrikson, Nora Beidler
Published 2019
Agency for Healthcare Research and Quality
...Twelve of 18 cases (66.7%) were detected at stage I or II or classified as "resectable." Pooled...

5
by Whitlock, Evelyn P., Williams, Selvi, Burda, Brittany U., Feightner, Alisha
Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
...When restricted to all trials of 100 mg or less, the risk tended to decrease (OR, 1.32 [95% CI...

6
by Whitlock, Evelyn P., Williams, Selvi, Burda, Brittany U., Feightner, Alisha
Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
...When restricted to all trials of 100 mg or less, the risk tended to decrease (OR, 1.32 [95% CI...

7
by Boustani, Malaz
Published 2003
Agency for Healthcare Research and Quality (US)
... of prevalence and accuracy of screening, we required cross-sectional or cohort studies in a primary care...

8
by Boustani, Malaz
Published 2003
Agency for Healthcare Research and Quality (US)
... of prevalence and accuracy of screening, we required cross-sectional or cohort studies in a primary care...